+689,905.7%
NVDA vs SBAC
+2,208.1%
+687,697.6%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -1.1% | +1.9% | +1.1% |
| 7D | +5.9% | -0.8% | +6.7% | +6.1% |
| 30D | +5.1% | +6.9% | -1.8% | +3.3% |
| 3M | +5.4% | -8.2% | +13.6% | +7.0% |
| 6M | +26.0% | -1.6% | +27.6% | +24.7% |
| YTD | +23.7% | -0.1% | +23.8% | +21.6% |
| 1Y | +34.4% | -0.5% | +34.8% | +31.9% |
| 3Y | +375.8% | -9.1% | +384.9% | +362.8% |
| 5Y | +911.8% | -43.8% | +955.5% | +1,015.0% |
| 10Y | +14,899.8% | +80.5% | +14,819.3% | +12,255.7% |
| All | +689,905.7% | +2,208.1% | +687,697.6% | +259,455.5% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling